An illustration picture shows vials with Covid-19 Vaccine stickers attached, with the logo of US pharmaceutical company Pfizer, on November 17, 2020. JUSTIN TALLIS / AFP
COVID-19: Pfizer Seeks Vaccine Approval As US Cases Rise
US giant Pfizer and its German partner BioNTech confirmed they would seek approval on Friday to roll out their coronavirus vaccine early as surging infections forced New York to shut schools and California braced for nighttime curfews.
The world is looking to scientists for salvation from the global pandemic but a second wave of infections is prompting a return to the shutdowns and closures that traumatised nations and upturned the global economy at the start of the year.
The first tangible signs of relief could come Friday when Pfizer and BioNTech file an emergency use authorisation request with the US Food and Drug Administration.
“Our work to deliver a safe and effective vaccine has never been more urgent,” Pfizer chief executive Albert Bourla said. “Filing in the US represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world.”
The scientific head of the US operation to develop a vaccine said the final green light would probably come in December.
What happens when legacy meets preparedness? What results from such a combination? Let us not…
Fidelity Bank has increased its staff salaries. Glamtush reports that tier-one lender, Fidelity Bank…
A man sentenced to death for the 1989 murder of his wife and her two…
Donald Trump’s administration said Thursday it had revoked Harvard’s right to enroll foreign students amid…
NASS leadership has endorsed Tinubu for the 2027 presidential race. Glamtush reports that the leaders…
Pastor Adeboye visited Plateau and offered his sympathy over the violent attacks in the state.…
![](data:image/svg+xml;charset=utf-8,<svg height="250px" width="660px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="350px" width="650px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
